Your AMERSA board members are closely monitoring the COVID-19 situation and are thinking about the safety and well-being of members and the people we all serve. Please reach out with information you’d like to share and questions to be answered. We are here for you!
From the 2020 AMERSA Conference: Caring for People who use Substances in the Context of COVID-19: Challenges, Opportunities and Lessons Learned \
Moderator: Hillary Kunins, MD, MPH, MS
Speakers: Chinazo Cunningham, MD, MS, Associate Chief, Division of General Internal Medicine; Professor of Medicine, Montefiore Health Center & Albert Einstein College of Medicine, Shannon Smith-Bernardin, PhD, RN, CNL, Assistant Adjunct Faculty, University of California-San Francisco School of Nursing; President & Co-Founder, National Sobering Collaborative President & Co-Founder, National Sobering Collaborative Assistant Adjunct Faculty, University of California-San Francisco School of Nursing, Hiawatha Collins, Community Mobilization Coordinator, National Harm Reduction Coalition and Meaghan Anne Thumath, RN, BSN, MPH, D.LSHTM, Clinician Scientist and Clinical Assistant Professor, School of Nursing, University of British Columbia; DPhil candidate and Trudeau Scholar, Centre for Evidence Based Intervention, University of Oxford; COVID-19 Vulnerable Populations Clinical Advisor, Vancouver Coastal Health
American Society of Addiction Medicine Coronavirus Resources
California Society of Addiction Medicine COVID-19 Updates
California Bridge Project Information on Substance Use Disorder (SUD) and COVID-19
Drug Enforcement Agency COVID-19 Information Page
Drug Policy Alliance Coronavirus (COVID-19) Resources
Harm Reduction Coalition COVID-19 Guidance for People Who Use Drugs and Harm Reduction Programs and Drug Overdose Prevention & Education (DOPE) Project: San Francisco – Harm Reduction Coalition
National Health Care for the Homeless Council Coronavirus and Influenza Resources
National Institute on Drug Abuse COVID-19 Resources
Substance Abuse and Mental Health Administration Coronavirus (COVID-19)
FAQs for Opioid Use Disorder Prescribing and Dispensing in the COVID-19 Emergency
MARA (Medication-Assisted Recovery Anonymous) Meetings
Starting Tuesday, March 24th at 11a – 12pm EST
Every week on Tuesdays and Thursdays
Join Zoom Meeting
https://zoom.us/j/602750376
Meeting ID: 602 750 376
One tap mobile
+13126266799, 602750376# US (Chicago)
+16468769923, 602750376# US (New York)
Dial by your location
+1 312 626 6799 US (Chicago)
+1 646 876 9923 US (New York)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US
+1 301 715 8592 US
+1 346 248 7799 US (Houston)
+1 408 638 0968 US (San Jose)
Meeting ID: 602 750 376
For Members in Canada
Helpful links from the Canadian Society of Addiction Medicine are available here: https://csam-smca.org/info-on-addictions-and-covid-19/